Overview
Intravenous stem cell infusion delivers stem cells directly into the bloodstream for systemic distribution. This approach is used for conditions affecting multiple systems or when localized injection is not practical.
In-Depth: IV Infusion
Intravenous (IV) stem cell infusion is a systemic regenerative treatment in which stem cells are delivered directly into the bloodstream through an intravenous drip. Unlike localized injections that target a specific joint or tissue, IV infusion allows stem cells to circulate throughout the entire body, where they may be drawn to areas of inflammation, tissue damage, and disease activity. This approach is typically used for conditions that affect multiple body systems or organs — such as autoimmune diseases, neurological conditions, and systemic inflammation — where localized injection would not be practical or sufficient.
The stem cells used for IV infusion may come from various sources, including the patient's own bone marrow or fat tissue (autologous), donated umbilical cord tissue, or in some cases, expanded cell lines. The infusion is typically administered in a clinical setting over the course of one to several hours, during which the patient is monitored for any adverse reactions. Proponents of IV stem cell therapy suggest that the infused MSCs home to inflamed or damaged tissues, where they exert anti-inflammatory and immunomodulatory effects, secrete growth factors and other regenerative molecules, and potentially stimulate local tissue repair.
IV stem cell infusion is among the more expensive and controversial regenerative treatments available. It is the treatment most commonly offered for conditions like MS, COPD, rheumatoid arthritis, and general anti-aging, but the clinical evidence for most of these applications remains limited. The FDA has taken enforcement action against some clinics offering IV stem cell treatments using products that have not been approved. Patients considering IV stem cell infusion should carefully evaluate the evidence for their specific condition, the credentials and transparency of the clinic, and the source and quality of the stem cell product being used. This is also one of the most expensive regenerative treatments, often costing $15,000 to $30,000 or more per session.
How It Works
- 1 Stem cells are sourced and prepared (autologous or donor)
- 2 The patient receives the cells through an IV drip
- 3 Stem cells circulate throughout the body via the bloodstream
- 4 Cells are attracted to areas of inflammation and damage
- 5 Systemic anti-inflammatory and regenerative effects occur over weeks
Best For
Risks & Side Effects
- Potential immune reactions including fever, chills, headache, and nausea during or after infusion
- Risk of pulmonary embolism if cells clump or if the product is not properly prepared
- Infection risk from the IV procedure itself or from contaminated cell products
- Rare but serious risk of tumor formation if cell products are not properly screened
- No guarantee of benefit — many conditions treated with IV infusion have limited clinical evidence
- Very high cost ($15,000-$30,000+) with no insurance coverage
Who Is a Good Candidate?
- May be considered: Patients with systemic conditions (autoimmune diseases, neurological conditions) where localized treatment is not practical
- May be considered: Patients who have not responded adequately to conventional medical treatments
- May be considered: Patients seeking treatment at reputable clinics with physician oversight and monitoring
- Use caution: Patients should verify the regulatory compliance and quality testing of the cell product
- Not recommended: Patients who have not been thoroughly evaluated and diagnosed by a specialist for their condition